PCSK6 and Survival in Idiopathic Pulmonary Fibrosis

RATIONALE: Idiopathic pulmonary fibrosis (IPF) is a devastating disease characterized by limited treatment options and high mortality. A better understanding of the molecular drivers of IPF progression is needed. OBJECTIVES: To identify and validate molecular determinants of IPF survival. METHODS: A...

Descripción completa

Detalles Bibliográficos
Autores principales: Oldham, Justin M., Allen, Richard J., Lorenzo-Salazar, Jose M., Molyneaux, Philip L., Ma, Shwu-Fan, Joseph, Chitra, Kim, John S., Guillen-Guio, Beatriz, Hernández-Beeftink, Tamara, Kropski, Jonathan A., Huang, Yong, Lee, Cathryn T., Adegunsoye, Ayodeji, Pugashetti, Janelle Vu, Linderholm, Angela L., Vo, Vivian, Strek, Mary E., Jou, Jonathan, Muñoz-Barrera, Adrian, Rubio-Rodriguez, Luis A., Hubbard, Richard, Hirani, Nik, Whyte, Moira K. B., Hart, Simon, Nicholson, Andrew G., Lancaster, Lisa, Parfrey, Helen, Rassl, Doris, Wallace, William, Valenzi, Eleanor, Zhang, Yingze, Mychaleckyj, Josyf, Stockwell, Amy, Kaminski, Naftali, Wolters, Paul J., Molina-Molina, Maria, Banovich, Nicholas E., Fahy, William A., Martinez, Fernando J., Hall, Ian P., Tobin, Martin D., Maher, Toby M., Blackwell, Timothy S., Yaspan, Brian L., Jenkins, R. Gisli, Flores, Carlos, Wain, Louise V., Noth, Imre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Thoracic Society 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10263132/
https://www.ncbi.nlm.nih.gov/pubmed/36780644
http://dx.doi.org/10.1164/rccm.202205-0845OC

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10263132/
https://www.ncbi.nlm.nih.gov/pubmed/36780644
http://dx.doi.org/10.1164/rccm.202205-0845OC

Ejemplares similares